| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,020 |
4,654 |
$368K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,204 |
4,756 |
$222K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,869 |
1,762 |
$207K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,378 |
1,377 |
$131K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,806 |
1,650 |
$87K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,232 |
1,231 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,527 |
2,417 |
$43K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
272 |
272 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,670 |
2,585 |
$39K |
| 99215 |
Prolong outpt/office vis |
146 |
141 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
510 |
480 |
$7K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
70 |
70 |
$4K |
| 99201 |
|
104 |
104 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
60 |
59 |
$3K |
| 87807 |
|
206 |
202 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
54 |
53 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$877.32 |
| 87400 |
|
27 |
26 |
$339.39 |